Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

EC approves Pfizer’s acute lymphoblastic leukemia treatment Besponsa

pharmaceutical-technologyJuly 05, 2017

Tag: Pfizer , acute lymphoblastic leukemia , Besponsa

PharmaSources Customer Service